Companies by Supersector - Health Care
| EPIC | Company | Index | Dividend Yield | Market Cap | Price Close | % Change |
|---|---|---|---|---|---|---|
| PYC | Physiomics | AIM | – | 0.27 | -3.80% | |
| TLY | Totally | AIM | – | 0.24 | -1.90% | |
| POLX | Polarean Imaging | AIM | – | 0.09 | -3.20% | |
| TRLS | Trellus Health | AIM | – | 0.50 | 7.30% | |
| GUN | Gunsynd | AIM | £2.14M | 0.13 | 9.50% | |
| BELL | Belluscura | AIM | £3.01M | 0.75 | -1.10% | |
| VAL | ValiRx | AIM | £3.12M | 0.39 | -2.20% | |
| MHC | MyHealthChecked | AIM | £4.55M | 8.75 | 5.30% | |
| SUN | Surgical Innovations Group | AIM | £5.13M | 0.46 | -2.30% | |
| TRX | Tissue Regenix Group | AIM | £5.16M | 7.25 | -1.50% | |
| PRM | Proteome Sciences | AIM | £6.97M | 1.88 | 8.00% | |
| OPTI | OptiBiotix Health | AIM | £6.97M | 6.50 | -3.30% | |
| RUA | RUA Life Sciences | AIM | £7.45M | 12.15 | -6.90% | |
| FUM | Futura Medical | AIM | £7.55M | 1.19 | 14.60% | |
| AGL | Angle | AIM | £7.72M | 2.40 | -0.70% | |
| GENI | Genincode | AIM | £8.03M | 2.58 | 1.40% | |
| GDR | Genedrive | AIM | £8.75M | 0.81 | -1.60% | |
| CEL | Celadon Pharmaceuticals | AIM | £9.23M | 13.40 | % | |
| OBD | Oxford BioDynamics | AIM | £10.3M | 0.23 | -4.00% | |
| IXI | Ixico | AIM | £10.89M | 11.75 | -1.50% | |
| VRCI | Verici Dx | AIM | £11.73M | 0.78 | -4.80% | |
| COG | Cambridge Cognition Holdings | AIM | £12.56M | 30.00 | -0.40% | |
| EDEN | Eden Research | AIM | £12.8M | 2.63 | -2.40% | |
| IHC | Inspiration Healthcare Group | AIM | £14.12M | 15.90 | 0.60% | |
| FAB | Fusion Antibodies | AIM | £18.19M | 15.00 | 25.90% | |
| SAR | Sareum Holdings | AIM | £24.16M | 16.41 | -5.60% | |
| NCYT | Novacyt SA | AIM | £26.6M | 38.50 | 4.20% | |
| POLB | Poolbeg Pharma | AIM | £27.54M | 4.02 | -2.10% | |
| ABDX | Abingdon Health | AIM | £29.25M | 6.75 | 2.60% | |
| AREC | Arecor Therapeutics | AIM | £30.39M | 85.00 | -1.30% | |
| IMM | ImmuPharma | AIM | £31.17M | 6.00 | -3.00% | |
| OHGR | One Health Group | AIM | 0.02 | £34.41M | 251.90 | % |
| SBTX | SkinBioTherapeutics | AIM | £35.26M | 13.00 | -14.90% | |
| CREO | Creo Medical Group | AIM | £40.85M | 10.50 | -0.80% | |
| OBI | Ondine Biomedical Inc | AIM | £43.31M | 10.00 | 2.60% | |
| HVO | Hvivo | AIM | 3.05 | £44.56M | 7.00 | -5.10% |
| KMK | Kromek Group | AIM | £55.68M | 8.53 | 8.70% | |
| ANIC | Agronomics | AIM | £70.66M | 7.02 | -0.60% | |
| EAH | Eco Animal Health Group | AIM | £72.16M | 106.50 | -4.30% | |
| SDI | SDI Group | AIM | £78.41M | 79.80 | -1.50% | |
| SPEC | Inspecs Group | AIM | £87.44M | 72.00 | -0.30% | |
| BVXP | Bioventix | AIM | 8.57 | £88.82M | 1,731.00 | -2.20% |
| 4BB | 4basebio | AIM | £100.6M | 650.00 | -0.40% | |
| ANP | Anpario | Main Market | 2.34 | £100.92M | 481.00 | -0.90% |
| SCLP | Scancell Holdings | AIM | £105.85M | 10.18 | -1.10% | |
| EKF | EKF Diagnostics Holdings | AIM | £108.85M | 25.30 | 1.00% | |
| DXRX | Diaceutics | AIM | £112.92M | 128.00 | -0.50% | |
| STX | Shield Therapeutics | AIM | £124.76M | 11.56 | -7.90% | |
| BMK | Benchmark Holdings | AIM | £135.69M | 22.05 | 1.50% | |
| MXCT | Maxcyte Inc | AIM | £161.75M | 147.69 | -1.20% | |
| ANCR | Animalcare Group | AIM | 2.18 | £164.33M | 238.00 | -2.60% |
| FARN | Faron Pharmaceuticals OY | AIM | £182.24M | 165.00 | 1.10% | |
| TSTL | Tristel | Main Market | 3.46 | £195.76M | 425.00 | 1.60% |
| NIOX | Niox Group | AIM | 1.82 | £287.5M | 69.00 | % |
| PRTC | Puretech Health | FTSE Small Cap | £291.47M | 125.00 | 3.65% | |
| AVCT | Avacta Group | AIM | £312.07M | 65.22 | -7.00% | |
| AMS | Advanced Medical Solutions Group | AIM | 1.24 | £466.98M | 222.50 | 3.10% |
| SPI | Spire Healthcare Group | FTSE 250 | 1.38 | £669.39M | 168.00 | 1.08% |
| AGY | Allergy Therapeutics | AIM | £706.27M | 11.05 | -2.50% | |
| OXB | Oxford BioMedica | FTSE Small Cap | £707.56M | 584.00 | -0.51% | |
| UPR | Uniphar | AIM | 0.01 | £797.12M | 308.48 | 0.90% |
| INDV | Indivior | FTSE 250 | £1.54B | 1,238.00 | -3.10% | |
| GNS | Genus | FTSE 250 | 1.26 | £1.69B | 2,600.00 | 2.16% |
| HCM | Hutchmed China | AIM | £1.74B | 204.00 | 4.80% | |
| HIK | Hikma Pharmaceuticals | FTSE 100 | 4.14 | £3.36B | 1,510.00 | -0.26% |
| CTEC | ConvaTec Group | FTSE 100 | 2.08 | £4.73B | 242.80 | 0.25% |
| SN. | Smith & Nephew | FTSE 100 | 2.35 | £10.39B | 1,230.50 | 0.61% |
| HLN | Haleon | FTSE 100 | 1.87 | £32.89B | 370.40 | 0.30% |
| GSK | GSK | FTSE 100 | 3.33 | £74.74B | 1,812.50 | -1.15% |
| AZN | AstraZeneca | FTSE 100 | 1.76 | £210.19B | 13,548.00 | -0.04% |